References
- Stoll BJ, Hansen NI, Bell EF, et al; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Neonatal outcomes of extremely preterm infants from the NICHD Neonatal Research Network. Pediatrics 2010;126:443–56
- Stephens BE, Tucker R, Vohr BR. Special health care needs of infants born at the limits of viability. Pediatrics 2010;125:1152–8
- Wood NS, Marlow N, Costeloe K, et al. EPICure Study Group. Neurologic and developmental disability after extremely preterm birth. EPICure Study Group. N Engl J Med 2000;343:378–84
- Hintz SR, Kendrick DE, Wilson-Costello DE, et al. NICHD Neonatal Research Network. Earlychildhood neurodevelopmental outcomes are not improving for infants born at 25 weeks' gestational age. Pediatrics 2011;127:62–70
- Roberts D, Dalziel S. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev 2006;3:CD004454
- NIH Consensus Development Panel on the effect of corticosteroids for fetal maturation on perinatal outcomes. Effect of corticosteroids for fetal maturation on perinatal outcomes. JAMA 1995;273:413–18
- ACOG Committee on Obstetric Practice. ACOG Committee Opinion No. 475: antenatal corticosteroide therapy for fetal maturation. Obstet Gynecol 2011;117:422–4
- Kollée LA, Cuttini M, Delmas D, et al.; MOSAIC Research Group. Obstetric interventions for babies born before 28 weeks of gestation in Europe: results of the MOSAIC study. BJOG 2009;116:1481–91
- Newnham JP, Jobe AH. Should we be prescribing repeated courses of antenatal corticosteroids? Semin Fetal Neonatal Med 2009;14:157–63
- Onland W, de Laat MW, Mol BW, Offringa M. Effects of antenatal corticosteroids given prior to 26 weeks gestation: a systematic review of randomized controlled trials. Am J Perinatol 2011;28:33–44
- Stiles AD. Prenatal corticosteroids early gain, longterm questions. N Engl J Med 2007;357:1248–50
- Chawla S, Bapat R, Pappas A, et al. Neurodevelopmental outcome of extremely premature infants exposed to incomplete, no or completeantenatal steroids. J Matern Fetal Neonatal Med 2013;26:1542–7
- Carlo WA, McDonald SA, Fanaroff AA, et al.; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Association of antenatal corticosteroids with mortality and neuro developmental outcomes among infants born at 22 to 25 weeks' gestation. JAMA 2011;306:2348–58
- Leviton A, Kuban KC, Pagano M, et al. Antenatal corticosteroids appear to reduce the risk of germinal matrix hemorrhage in intubated low birth weight newborns. Pediatrics 1993;91:1083–8
- Wright LL, Horbar JD, Gunkel H. Evidence from multicenter networks on the current use and effectiveness of antenatal corticosteroids in low birth weight infants. Am J Obstet Gynecol 1995;173:263–9
- Figueras-Aloy J, Serrano MM, Rodrıguez JP, et al; SEN1500 Spanish Neonatal Network. Antenatal glucocorticoid treatment decreases mortality and chronic lung disease in survivors among 23- to 28-week gestational age preterm infants. Am J Perinatol 2005;22:441–8
- Mori R, Kusuda S, Fujimura M; Neonatal Research Network Japan. Antenatal corticosteroids promote survival of extremely preterm infants born at 22 to 23 weeks of gestation. J Pediatr 2011;159:110-14, e1
- Costeloe K, Hennessy E, Gibson AT, et al. EPICure Study Group. The EPICure study: outcomes to discharge from hospital for infants born at the threshold of viability. Pediatrics 2000;106:659–71
- Hayes EJ, Paul DA, Stahl GE, et al. Effect of antenatal corticosteroids on survival for neonates born at 23 weeks of gestation. Obstet Gynecol 2008;111:921–6
- Abbasi S, Oxford C, Gerdes J, et al. Antenatal corticosteroids prior to 24 weeks' gestation and neonatal outcome of extremely low birth weight infants. Am J Perinatol 2010;27:61–6